Search Result "Low doses metronomic"
Impaired Autophagy Mediates Resistance to Low-Dose Metronomic Cyclophosphamide Chemotherapy
Journal: Clinical Cancer Drugs
Volume: 1 Issue: 2 Year: 2014 Page: 116-126
Author(s): Annabelle Chow,Giulio Francia,Andrew Kouri,Christina Lee,John M. Ebos,Robert S. Kerbel,Urban Emmenegger
Can Targeted Therapy be Successful without Metronomic Scheduling ?
Journal: Current Topics in Medicinal Chemistry
Volume: 12 Issue: 15 Year: 2012 Page: 1639-1642
Author(s): Nicolas Andre,Eddy Pasquier,Barton Kamen
Muscarinic Receptors as Targets for Metronomic Therapy in Breast Cancer
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 14 Year: 2016 Page: 2170-2177
Author(s): MarÃa Elena Sales
Metronomic Therapy for Multi Relapsed/Refractory Lymphoma. A Pilot Study
Journal: Current Angiogenesis (Discontinued)
Volume: 2 Issue: 2 Year: 2013 Page: 119-125
Author(s): Shebli Atrash,Bakhous Aziz,Xenofon Papanikolaou,Abdallah Al-Ola,Muzaffar Jameel,Kumar Surachit,Sarah Waheed,Frits Van Rhee,Saad Z. Usmani,Bart Barlogie
A Single Center Phase II Study of Continuous Infusion of Low-dose 5- fluorouracil for Heavily Pretreated Patients With Metastatic Colorectal Cancer
Journal: Clinical Cancer Drugs
Volume: 2 Issue: 2 Year: 2015 Page: 87-90
Author(s): Hong-tao Chen, Yi-feng Liao, Mei Xiao, Lin Ma, Hong-Yu Zhang
New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy
Journal: Current Cancer Drug Targets
Volume: 5 Issue: 6 Year: 2005 Page: 393-419
Author(s): Christian Hafner, Albrecht Reichle, Thomas Vogt
Role of Muscarinic Acetylcholine Receptors in Breast Cancer: Design of Metronomic Chemotherapy
Journal: Current Clinical Pharmacology
Volume: 14 Issue: 2 Year: 2019 Page: 91-100
Author(s): MarÃa E. Sales,Alejandro J. Español,Agustina R. Salem,Paola M. Pulido,Y. Sanchez,Francisco Sanchez
Cellular and Molecular Surrogate Markers to Monitor Targeted and Non- Targeted Antiangiogenic Drug Activity and Determine Optimal Biologic Dose
Journal: Current Cancer Drug Targets
Volume: 5 Issue: 7 Year: 2005 Page: 551-559
Author(s): Yuval Shaked, Guido Bocci, Raquel Munoz, Shan Man, John M.L. Ebos, Daniel J. Hicklin, Francesco Bertolini, Robert DAmato, Robert S. Kerbel
Increased Tumor Oxygenation and Drug Uptake During Anti-Angiogenic Weekly Low Dose Cyclophosphamide Enhances the Anti-Tumor Effect of Weekly Tirapazamine (Supplementry Material)
Journal: Current Cancer Drug Targets
Volume: 9 Issue: 6 Year: 2009 Page: 777-788
Author(s): J. C. Doloff, N. Khan, J. Ma, E. Demidenko, H. M. Swartz, Y. Jounaidi
Anti-Angiogenic Therapies for Children with Cancer
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 8 Year: 2010 Page: 879-889
Author(s): N. Andre, A. Verschuur, J. Rossler, J. Sterba